AGP Executive Report
Last update: 30 minutes agoBiotech Commercial Push: Insight Molecular Diagnostics (iMDx) says it’s moving fast toward commercialization of its GraftAssureDx kidney transplant rejection test, citing growing customer demand and a path to FDA authorization later in 2026, with new clinical trial agreements and expected follow-on U.S. orders. Battery Supply Momentum: Microporous secured offtake agreements totaling over half a billion square meters annually for ionForce® battery separators, supporting 50+ GWh of capacity and backing expansion in Virginia. Retail Earnings Reality Check: Grocery Outlet reported Q1 fiscal 2026 net sales up to $1.17B, but an operating loss tied to goodwill impairment and restructuring. Public Safety Tech Backlash: Tennessee schools faced swatting hoaxes again, with the FBI warning the tactic is rising nationwide. Healthcare Access: Athens-Limestone Hospital expanded advanced MRI access for cardiac device patients using remote programming. Local Business & Jobs: FedEx board approved the FedEx Freight spinoff, set to finish by June 1. Education Pressure: A new national report says the “reading recession” began years before COVID and remains severe.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
